# Satsuma Pharmaceuticals (stock symbol: STSA) Logo in transparent PNG and SVG formats

## Satsuma Pharmaceuticals Logo large

### Satsuma Pharmaceuticals Logo large Download PNG (30.82 KB)

![Satsuma Pharmaceuticals Logo large Download PNG (30.82 KB)](/img/orig/STSA_BIG-4e3fa32e.png)

### Satsuma Pharmaceuticals Logo large Download SVG (6.33 KB)

![Satsuma Pharmaceuticals Logo large Download SVG (6.33 KB)](/img/orig/STSA_BIG-b0d23235.svg)

## Satsuma Pharmaceuticals Logo icon format

### Satsuma Pharmaceuticals Logo icon format Download PNG (55.38 KB)

![Satsuma Pharmaceuticals Logo icon format Download PNG (55.38 KB)](/img/orig/STSA-2d8ae1f6.png)

### Satsuma Pharmaceuticals Logo icon format Download SVG (1.93 KB)

![Satsuma Pharmaceuticals Logo icon format Download SVG (1.93 KB)](/img/orig/STSA-a12fbde4.svg)

## Satsuma Pharmaceuticals Logo large for dark backgrounds

### Satsuma Pharmaceuticals Logo large for dark backgrounds Download PNG (19.35 KB)

![Satsuma Pharmaceuticals Logo large for dark backgrounds Download PNG (19.35 KB)](/img/orig/STSA_BIG.D-471fa8d3.png)

### Satsuma Pharmaceuticals Logo large for dark backgrounds Download SVG (6.31 KB)

![Satsuma Pharmaceuticals Logo large for dark backgrounds Download SVG (6.31 KB)](/img/orig/STSA_BIG.D-754b31fe.svg)

## Satsuma Pharmaceuticals Logo icon format for dark backgrounds

### Satsuma Pharmaceuticals Logo icon format for dark backgrounds Download PNG (33.07 KB)

![Satsuma Pharmaceuticals Logo icon format for dark backgrounds Download PNG (33.07 KB)](/img/orig/STSA.D-b7b00332.png)

### Satsuma Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.9 KB)

![Satsuma Pharmaceuticals Logo icon format for dark backgrounds Download SVG (1.9 KB)](/img/orig/STSA.D-d434156b.svg)

## About Satsuma Pharmaceuticals

Satsuma Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, developing novel therapeutic products for the acute treatment of migraines. The company's lead product candidate is STS101, a drug-device combination of a proprietary dry-powder formulation of dihydroergotamine mesylate, which is in SUMMIT Phase 3 efficacy trials and can be self-administered with proprietary pre-filled, single-use, and nasal delivery device. Satsuma Pharmaceuticals, Inc. was incorporated in 2016 and is headquartered in South San Francisco, California.

1. Website domain: satsumarx.com
2. Employees: 25
3. Marketcap: $35.14 Million USD


## Categories
- [x] ðŸ‡ºðŸ‡¸ United States
- [x] ðŸ’Š Pharmaceuticals
- [x] ðŸ§¬ Biotech
